Best Practice & Research Clinical Rheumatology
Volume 20, Issue 1 , Pages 99-115 , February 2006

Nutraceuticals: do they work and when should we use them?

References 

  1. Theodosakis J, Adderly B, Fox B. The Arthritis Cure. New York: St. Martin's Press; 1997;
  2. Marra J. The state of dietary suplements—even slight increases in growth are better than no growth at all. Nutraceuticals World. 2002;32–40
  3. Anonymous US. Nutrition Industry: top 70 supplements 1997–2001. Nutrition Business Journal. 2001;[Chart 14]
  4. Frei B. Reactive oxygen species and antioxidant vitamins: mechanisms of action. The American Journal of Medicine. 1994;97(supplement 3A):5S–13S
  5. Boveris A, Oshino N, Chance B. The cellular production of hydrogen peroxide. The Biochemical Journal. 1972;128:617–630
  6. Blake DR, Unsworth J, Outhwaite JM, et al. Hypoxic-reperfusion injury in the inflamed human. Lancet. 1989;11:290–293
  7. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants and the degenerative diseases of aging. Proceedings of the National Academy Science of the United Science of America. 1993;90:7915–7922
  8. Jacques PF, Chylack LT, Taylor A. Relationships between natural antioxidants and cataract formation. In:  Frei B editors. Natural Antioxidants in Human Health and Disease. San Diego, CA: Academic Press; 1994;p. 515–533
  9. Gaziano JM. Antioxidant vitamins and coronary artery disease risk. The American Journal of Medicine. 1994;97(supplement 3A):18S–21S
  10. Hennekens CH. Antioxidant vitamins and cancer. The American Journal of Medicine. 1994;97(supplement 3A):2S–4S
  11. Martin JA, Buckwalter JA. Aging, articular cartilage chondrocyte senescence and osteoarthritis. Biogerontology. 2002;3(5):257–264
  12. Henrotin Y, Deby-Dupont G, Deby C, et al. Production of active oxygen species by isolated human chondrocytes. British Journal Rheumatology. 1993;32(7):562–567
  13. Henrotin Y, Deby-Dupont G, Deby C, et al. Active oxygen species, articular inflammation, and cartilage damage. Exs. 1992;62:308–322
  14. Rathakrishnan C, Tiku K, Raghavan A, Tiku ML. Release of oxygen radicals by articular chondrocytes: a study of luminol-dependent chemoluminescence and hydrogen peroxide secretion. Journal of Bone and Mineral Research. 1992;7:1139–1148
  15. Tiku ML, Allison GT, Naik K, Karry SK. Malondialdehyde oxidation of cartilage collagen by chondrocytes. Osteoarthritis and Cartilage. 2003;11(3):159–166
  16. Greenwald RA, Moy WW. Inhibition of collagen gelation by action of the superoxide radical. Arthritis and Rheumatism. 1979;22(3):251–259
  17. McCord JM. Free radicals and inflammation: protection of synovial fluid by superoxide dismutase. Science. 1974;185:529–530
  18. Loeser RF, Carlson CS, Del Carlo M, Cole A. Detection of nitrotyrosine in aging and osteoarthritic cartilage: correlation of oxidative damage with the presence of interleukin-1beta and with chondrocyte resistance to insulin-like growth factor 1. Arthritis and Rheumatism. 2002;46(9):2349–2357
  19. Yudoh K, Nguyen T, Nakamura H, et al. Potential involvement of oxidative stress in cartilage senescence and development of osteoarthritis: oxidative stress induces chondrocyte telomere instability and downregulation of chondrocyte function. Arthritis Reserach and Therapy. 2005;7(2):R380–R391
  20. Haklar U, Yuksel M, Velioglu A, et al. Oxygen radicals and nitric oxide levels in chondral or meniscal lesions or both. Clinical Orthopaedics and Releated Research. 2002;(403):135–142
  21. Sato H, Takahashi T, Ide H, et al. Antioxidant activity of synovial fluid, hyaluronic acid, and two subcomponents of hyaluronic acid. Synovial fluid scavenging effect is enhanced in rheumatoid arthritis patients. Arthritis and Rheumatism. 1988;31(1):63–71
  22. Briviba K, Seis H. Non-enzymatic antioxidant defense systems. In:  Frei B editors. Natural Antioxidants in Human Health and Disease. San Diego: Academic Press; 1994;p. 107–128
  23. Hankinson SE, Stampfer MJ, Seddon JM, et al. Nutrient intake and cataract extraction in women: a prospective study. British Medical Journal. 1992;305(6849):335–339
  24. Peterkofsky B. Ascorbate requirement for hydroxylation and secretion of procollagen: relationship to inhibition of collagen synthesis in scurvy. The American Journal of Clinical Nutrition. 1991;54:1135S–1140S
  25. Spanheimer RG, Bird TA, Peterkofsky B. Regulation of collagen synthesis and mRNA levels in articular cartilage of scorbutic guinea pigs. Archives Biochemistryand Biophysics. 1986;246:33–41
  26. Houglum KP, Brenner DA, Chijkier M. Ascorbic acid stimulation of collagen biosynthesis independent of hydroxylation. The American Journal of Clinical Nutrition. 1991;54:1141S–1143S
  27. Schwartz ER, Adamy L. Effect of ascorbic acid on arylsulfatase activities and sulfated proteoglycan metabolism in chondrocyte cultures. Journal of Clinical Investigation. 1977;60(1):96–106
  28. Sandell LJ, Daniel LC. Effects of ascorbic acid on collagen mRNA levels in short-term chondrocyte cultures. Connective Tissue Research. 1988;17:11–22
  29. Setnikar I, Ralumbo R, Canali S, Zanolo G. Pharmacokinetics of glucosamine in man. Drug Research. 1993;43:1109–1113
  30. Setnikar I, Giachetti C, Zanolo G. Absorption, distribution and excretion of radio-activity after a single I.V. or oral administration of [14C]glucosamine to the rat. Pharmatherapeutica. 1984;3:358
  31. Aghazadeh-Habashi A, Sattari S, Pasutto F, Jamali F. Single dose pharmacokinetics and bioavailability of glucosamine in the rat. Journal of Pharmacy and Pharmacology Science. 2002;5(2):181–184
  32. Adebowale A, Du J, Liang Z, et al. The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogs. Biopharmaceutics and Drug Disposition. 2002;23(6):217–225
  33. Theodore G. Untrsuchung von 35 arhrosefallen, behandelt mit chondroitin schwefelsaure. Schweiz Rundschaue Medizin Praxis. 1977;66:
  34. Vach J, Pesakova V, Krajickova J, Adam M. Efect of glycosaminoglycan polysulfate on the metabolism of cartilage RNA. Arzneimittel-Forschung/Drug Research. 1984;34:607–609
  35. Ali SY. The degrdation of cartilage matrix by an intracellular protease. Biochemical Journal. 1964;93:611
  36. Hamerman D, Smith C, Keiser HD, Craig R. Glycosaminoglycans produced by human synovial cell cultures collagen. Related Research. 1982;2:313
  37. Lilja S, Barrach HJ. Normally sulfated and highly sulfated glycosaminoglycans affecting fibrillogenesis on type I and type II collage in vitro. Experiemental Pathology. 1983;23:173–181
  38. Knanfelt A. Synthesis of articular cartilage proteoglycans by isolated bovine chondrocytes. Agents Actions. 1984;14:58–62
  39. Baici A, Salgam P, Fehr K, Boni A. Inhibition of human elastase from polymorphonuclear leucocytes by gold sodium thiomalate and pentosan polysulfate (SP-54). Biochemical Pharmacology. 1981;30(7):703–708
  40. Baici A. Interactions between human leucocytes elastase and chondroitin sulfate. Chemico-Biological Interactions. 1984;51:11
  41. Marossy K. Interaction of the antitrypsin and elastase-like enzyme of the human granulocyte with glycosaminoglycans. Biochimica et Biophysica Acta. 1981;659:351–361
  42. De Gennaro F, Piccioni PD, Caporali R, et al. Effet du traitement par le sulfate de galactosaminoglucuronoglycane sur l'estase granulocytaire synovial de patients atteints d'osteoarthrose. Literatur Rhumatological. 1992;14:53–60
  43. Humphries DE, Silbert CK, Silbert JE. Glycosaminoglycan production by bovine aortic endothelial cells cultured in sulfate-depleted medium. Journal of Biological Chemistry. 1986;261(20):9122–9127
  44. Silbert CK, Humphries DE, Palmer ME, Silbert JE. Effects of sulfate deprivation on the production of chondroitin/dermatan sulfate by cultures of skin fibroblasts from normal and diabetic individuals. Archives of Biochemistry and Biophysics. 1991;285(1):137–141
  45. Silbert JE, Sugumaran G, Cogburn JN. Sulphation of proteochondroitin and 4-methylumbelliferyl beta-d-xyloside-chondroitin formed by mouse mastocytoma cells cultured in sulphate-deficient medium. Biochemical Journal. 1993;1(Pt 1):119–126
  46. van der Kraan PM, Vitters EL, de Vries BJ, van den Berg WB. High susceptibility of human articular cartilage glycosaminoglycan synthesis to changes in inorganic sulfate availability. Journal of Orthopaedic Research. 1990;8(4):565–571
  47. Morris ME, Levy G. Serum concentration and renal excretion by normal adults of inorganic sulfate after acetaminophen, ascorbic acid, or sodium sulfate. Clinical Pharmacology Therapeutics. 1983;33(4):529–536
  48. Cordoba F, Nimni ME. Chondroitin sulfate and other sulfate containing chondroprotective agents may exhibit their effects by overcoming a deficiency of sulfur amino acids. Osteoarthritis and Cartilage. 2003;11(3):228–230
  49. Corvol MT. Hormonal control of cartilage metabolism. Bulletin Schweizerischen Akademie Der Medizinischen Wissenschaften. 1981;205–209
  50. Corvol MT, Dumontier MF, Tsagris L, et al. Cartilage and vitamin D in vitro (author's transl). Annales Endocrinologie (Paris). 1981;42(4–5):482–487
  51. Tetlow LC, Woolley DE. Expression of vitamin D receptors and matrix metalloproteinases in osteoarthritic cartilage and human articular chondrocytes in vitro. Osteoarthritis and Cartilage. 2001;9(5):423–431
  52. Radin EL, Paul IL, Tolkoff MJ. Subchondral changes in patients with early degenerative joint disease. Arthritis and Rheumatism. 1970;13:400–405
  53. Layton MW, Goldstein SA, Goulet RW, et al. Examination of subchondral bone architecture in experimental osteoarthritis by microscopic computed axial tomography. Arthritis and Rheumatism. 1988;31(11):1400–1405
  54. Milgram JW. Morphological alterations of the subchondral bone in advanced degenerative arthritis. Clinical Orthopaedics Related Research. 1983;173:293–312
  55. Kellgren JH, Lawrence JS. The Epidemiology of Chronic Rheumatism: Atlas of Standard Radiographs. Oxford, UK: Blackwell Scientific; 1962;
  56. Anonymous. Cartilage and bone in osteoarthrosis. British Medical Journal 1976;2:4–5.
  57. Dequecker J, Mokassa L, Aerssens J. Bone density and osteoarthritis. The Journal of Rheumatology. 1995;22(supplement 43):98–100
  58. Dedrick DK, Goldstein SA, Brandt KD, et al. A longitudinal study of subchondral plate and trabecular bone in cruciate-deficient dogs with osteoarthritis followed up for 54 months. Arthritis and Rheumatism. 1993;36:1460–1467
  59. Ledingham J, Dawson S, Preston B, et al. Radiographic progression of hospital-referred osteoarthritis of the hip. Annals of the Rheumatic Diseases. 1993;52:263–267
  60. Radin EL, Rose RM. Role of subchondral bone in the initiation and progression of cartilage damage. Clinical Orthopaedics Related Research. 1986;213:34–40
  61. Pottenger LA, Phillips FM, Draganich LF. The effect of marginal osteophytes on reduction of varus-valgus instability in osteoarthritic knees. Arthritis and Rheumatism. 1990;33(6):853–858
  62. Perry GH, Smith MJG, Whiteside CG. Spontaneous recovery of the joint space in degenerative hip disease. Annals of the Rheumatic Diseases. 1972;31:440–448
  63. Smythe SA. Osteoarthritis, insulin and bone density. The Journal of Rheumatology. 1987;14(supplement):91–93
  64. Zhang Y, Hannan MT, Chaisson CE, et al. Bone mineral density and risk of incident and progressive radiographic knee osteoarthritis in women: the framingham study. The Journal of Rheumatology. 2000;27(4):1032–1037
  65. Dieppe P, Cushnaghan J, Young P, Kirwan J. Prediction of the progression of joint space narrowing in osteoarthritis of the knee by bone scintigraphy. Annals of the Rheumatic Diseases. 1993;52:557–563
  66. Kiel DP, Vitamin D. Calcium and bone: descriptive epidemiology. In:  Rosenberg IH editors. Nutritional Assessment of Elderly Populations: Measurement and Function. New York: Raven; 1995;p. 277–90
  67. Parfitt AM, Gallagher JC, Heaney RP, et al. Vitamin D and bone health in the elderly. The American Journal of Clinical Nutrition. 1982;36:1014–1031
  68. Panganamala RV, Cornwell DG. The effects of vitamin E on arachidonic acid metabolism. Annals of the New York Academy of Sciences. 1982;393:376–391
  69. Schwartz ER, Leveille C, Oh WH. Experimentally induced osteoarthritis in guinea pigs: effect of surgical procedure and dietary intake of vitamin C. Laboratory Animal Science. 1981;31:683–687
  70. Meacock SCR, Bodmer JL, Billingham MEJ. Experimental OA in guinea pigs. Journal of Experimental Pathology. 1990;71:279–293
  71. McAlindon TE, Jacques P, Zhang Y, et al. Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis?. Arthritis and Rheumatism. 1996;39(4):648–656
  72. Kellgren J, Lawrence JS. The Epidemiology of Chronic Rheumatism: Atlas of Standard Radiographs. vol. 2. Oxford: Blackwell Scientific; 1963;
  73. Baker K, Niu J, Goggins J, et al. The effects of vitamin C intake on pain in knee osteoarthritis (OA). Arthritis and Rheumatism. 2003;48(9):S422
  74. Hirohata K, Yao S, Imura S, Harada H. Treatment of osteoarthritis of the knee joint at the state of hydroarthrosis. The Kobe Medical Sciences. 1965;11(supplement):65–66
  75. Doumerg C. Etude clinique experimentale de l'alpha-tocopheryle-quinone en rheumatologie et en reeducation. Therapeutique. 1969;45:676–678
  76. Machetey I, Quaknine L. Tocopherol in osteoarthritis: a controlled pilot study. Journal of the American Geriatrics Society. 1978;26:328–330
  77. Scherak O, Kolarz G, Schodl C, Blankenhorn G. Hochdosierte vitamin-E-therapie bei patienten mit aktivierter arthrose. Zeitschrift fur Rheumatologie. 1990;49:369–373
  78. Blankenhorn G. Clinical efficacy of spondyvit (vitamin E) in activated arthroses. A multicenter, placebo-controlled, double-blind study. Zeitschrift fur Orthopadie. 1986;124:340–343
  79. Hill J, Bird HA. Failure of selenium-ace to improve osteoarthritis. British Journal Rheumatology. 1990;29(3):211–213
  80. Wluka AE, Stuckey S, Brand C, Cicuttini FM. Supplementary vitamin E does not affect the loss of cartilage volume in knee osteoarthritis: a 2 year double blind randomized placebo controlled study. Journal Rheumatology. 2002;29(12):2585–2591
  81. Utiger RD. Kashin-Beck disease—expanding the spectrum of iodine-deficiency disorders [editorial; comment]. The New England Journal of Medicine. 1998;339(16):1156–1158
  82. Moreno-Reyes R, Suetens C, Mathieu F, et al. Kashin-Beck osteoarthropathy in rural Tibet in relation to selenium and iodine status [see comments]. The New England Journal of Medicine. 1998;339(16):1112–1120
  83. McAlindon TE, Felson DT, Zhang Y, et al. Relation of dietary intake and serum levels of vitamin D to progression of osteoarthritis of the knee among participants in the framingham study. Annals of Internal Medicine. 1996;125(5):353–359
  84. Lane NE, Gore LR, Cummings SR, et al. Serum vitamin D levels and incident changes of radiographic hip osteoarthritis: a longitudinal study. Study of osteoporotic fractures research group. Arthritis and Rheumatism. 1999;42(5):854–860
  85. Flynn MA, Irvin W, Krause G. The effect of folate and cobalamin on osteoarthritic hands. Journal of the American College of Nutrition. 1994;13(4):351–356
  86. D'Ambrosio E, Casa B, Bompani R, et al. Glucosamine sulphate: a controlled clinical investigation in arthrosis. Pharmatherapeutica. 1981;2(8):504–508
  87. Crolle G, D'Este E. Glucosamine sulphate for the management of arthrosis: a controlled clinical investigation. Current Medical Research and Opinion. 1980;7(2):104–109
  88. Drovanti A, Bignamini AA, Rovati AL. Therapeutic activity of oral glucosamine sulfate in osteoarthrosis: a placebo-controlled double-blind investigation. Clinical Therapeutics. 1980;3(4):260–272
  89. Noack W, Fsicher M, Forster KK, et al. Glucosamine sulfate in osteoarthitis of the knee. Osteoarthritis and Cartilage. 1994;2:51–59
  90. Pujalte JM, Llavore EP, Ylescupidez FR. Double-blind clinical evaluation of oral glucosamine sulphate in the basic treatment of osteoarthrosis. Current Medical Research and Opinion. 1980;7(2):110–114
  91. Reichelt A, Forster KK, Fischer M, et al. Efficacy and safety of intramuscular glucosamine sulfate in osteoarthritis of the knee: a randomized, placebo-controlled, double-blind study. Drug Research. 1994;44:75–80
  92. Vaz AL. Double-blind clinical evaluation of the relative efficacy of ibuprofen and glucosamine sulphate in the management of osteoarthrosis of the knee in out-patients. Current Medical Research and Opinion. 1982;8:145–149
  93. Vajaradul Y. Double-blind clinical evaluation of intra-articular glucosamine in outpatients with gonarthrosis. Clinical Therapeutics. 1981;3(5):336–343
  94. Tapadinhas MJ, Rivera IC, Bignamini AA. Oral glucosamine sulphate in the management of arthosis: report on a multi-centre open investigation in portugal. Pharmatherapeutica. 1982;3(3):157–168
  95. Vetter VG. Glukosamine in der therapie des degenerativen rheumatismus. Duet Medical Journal. 1965;16:446–449
  96. L'Hirondel JL. Klinische doppelblind-studie mit oral verabreichtem chondroitinsulfat gegen placebo bei der tibiofemoralen gonarthrose (125 patienten). Literatur Rhumatologica. 1992;14:77–84
  97. Kerzberg EM, Roldan EJ, Castelli G, Huberman ED. Combination of glycosaminoglycans and acetylsalicylic acid in knee osteoarthrosis. Scandinavian Journal of Rheumatology. 1987;16(5):377–380
  98. Mazieres B, Loyau G, Menkes CJ, et al. Chondroitin sulfate in the treatment of gonarthrosis and coxarthrosis. 5-months result of a multicenter double-blind controlled prospective study using placebo. Revue du Rhumatisme et Des Maladies Osteo-Articulaires. 1992;59(7–8):466–472
  99. Rovetta G. Galactosaminoglycuronoglycan sulfate (matrix) in therapy of tibiofibular osteoarthritis of the knee. Drugs Exprimental Clinical Research. 1991;17:53–57
  100. Muller-Fassbender H, Bach GL, Haase W, et al. Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee. Osteoarthritis and Cartilage. 1994;2:61–69
  101. McAlindon TE, LaValley MP, Gulin JP, Felson DT. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. The Journal of the American Medical Association. 2000;283(11):1469–1475
  102. Towheed TE, Anastassiades TP, Shea B, et al. Glucosamine therapy for treating osteoarthritis (cochrane review). Cochrane Database of Systematic Reviews. 2001;1:
  103. Leeb BF, Schweitzer H, Montag K, Smolen JS. A metaanalysis of chondroitin sulfate in the treatment of osteoarthritis. The Journal of Rheumatology. 2000;27(1):205–211
  104. Cibere J, Esdaile JM, Thorne A, et al. Multicenter Randomized double-blind placebo-controlled glucosamine discontinuation trial in osteoarthritis. Arthritis and Rheumatism. 2002;46(supplement 9):S1549
  105. McAlindon T, Formica M, Kabbara K, et al. Conducting clinical trials over the internet: feasibility study. British Medical Journal. 2003;327(7413):484–487
  106. Hughes R, Carr A. A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee. Rheumatology (Oxford). 2002;41(3):279–284
  107. Rindone JP, Hiller D, Collacott E, et al. Randomized, controlled trial of glucosamine for treating osteoarthritis of the knee. West Journal of Medical. 2000;172(2):91–94
  108. Cibere J, Kopec JA, Thorne A, et al. Randomized, double-blind, placebo-controlled glucosamine discontinuation trial in knee osteoarthritis. Arthritis and Rheumatism. 2004;51(5):738–745
  109. Reginster JY, Deroisy R, Rovati LC, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet. 2001;357(9252):251–256
  110. Pavelka K, Gatterova J, Olejarova M, et al. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Archives of Internal Medicine. 2002;162(18):2113–2123
  111. Altman R, Brandt KD, Hochberg MC, Moskowitz R. Design and conduct of clinical trials in patients with osteoarthritis: recomendations from a task force of the Osteoarthritis Research Society. Osteoarthritis and Cartilage. 1996;4:217–243
  112. Michel BA, Stucki G, Frey D, et al. Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial. Arthritis and Rheumatism. 2005;52(3):779–786
  113. Ernst E. Avocado-soybean unsaponifiables (ASU) for osteoarthritis—a systematic review. Clinical Rheumatology. 2003;22(4–5):285–288
  114. Muller-Fassbender H. Double-blind clinical trial of S-adenosylmethionine versus ibuprofen in the treatment of osteoarthritis. The American Journal of Medicine. 1987;83(5A):81–83
  115. Konig B. A long-term (two years) clinical trial with S-adenosylmethionine for the treatment of osteoarthritis. The American Journal of Medicine. 1987;83(5A):89–94
  116. Vetter G. Double-blind comparative clinical trial with S-adenosylmethionine and indomethacin in the treatment of osteoarthritis. The American Journal of Medicine. 1987;83(5A):78–80
  117. Maccagno A, Di Giorgio EE, Caston OL, Sagasta CL. Double-blind controlled clinical trial of oral S-adenosylmethionine versus piroxicam in knee osteoarthritis. The American Journal of Medicine. 1987;83(5A):72–77
  118. Glorioso S, Todesco S, Mazzi A, et al. Double-blind multicentre study of the activity of S-adenosylmethionine in hip and knee osteoarthritis. International Journal of Clinical Pharmacology Research. 1985;5(1):39–49
  119. Najm WI, Reinsch S, Hoehler F, et al. S-adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: a double-blind cross-over trial. BMC Musculoskeletal Disorder. 2004;5(1):6;[ISRCTN36233495]
  120. Altman RD, Marcussen KC. Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis and Rheumatism. 2001;44(11):2531–2538

PII: S1521-6942(05)00103-8

doi: 10.1016/j.berh.2005.09.002

Best Practice & Research Clinical Rheumatology
Volume 20, Issue 1 , Pages 99-115 , February 2006

Article Tools